ANGELA JOHANNES: Open Payments
NPI 1699102285 · CHARLOTTE HALL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 20 payments from 7 companies in 2025. Trend: 2023 $261 · 2024 $133 · 2025 $363
Food & beverage: $264Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $172 |
| UCB, Inc. | 3 | $57 |
| PFIZER INC. | 3 | $55 |
| Incyte Corporation | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: TREMFYA, Bimzelx, CIBINQO, Opzelura, Winlevi, TRELEGY ELLIPTA, EUCRISA, NEMLUVIO.
Industry payments across MD — which companies pay providers there.
